INCA Launches First-Ever Global Survey to Measure Access Challenges to Optimal Neuroendocrine Tumor Care
In order to better understand the challenges of optimal care for neuroendocrine tumor (NET) patients, the International Neuroendocrine Cancer Alliance (INCA), of which the Carcinoid Cancer Foundation is a proud member, has launched SCAN - a global survey designed to capture both NET patients' and healthcare professionals' perspectives.
Rare Cancer Day will be observed for the first time on October 1, 2019 to shine a light on the challenges of living with rare cancers, unify individuals living with rare cancers, and raise awareness about early diagnosis. NORD, the National Organization for Rare Diseases, is offering a free webinar - Rare Cancers: Facts, Challenges and Patient Stories - for patients, caregivers, advocates and the public. Click here for more information and to register.
The Carcinoid Cancer Foundation's educational, awareness and advocacy activities are made possible by your contributions. These crucial activities lead toward early detection, improving the quality of life for cancer survivors, and ultimately to a cure. The Carcinoid Cancer Foundation is a 501(c)(3) nonprofit organization. All contributions to the Carcinoid Cancer Foundation are tax-deductible to the extent allowed by law. Thank you for your support.
Carcinoid Cancer Foundation
118 North Bedford Road, Suite 100
Mt. Kisco, NY 10549
118 N. Bedford Road Suite 100 | Mt. Kisco, NY 10549-2555 US